AbbVie Inc. v. Hetero USA, Inc. et al
| Delaware District Court | |
| Case #: | 1:24-cv-01254 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:271 Patent Infringement |
| Case Filed: | Nov 14, 2024 |
| Last checked: Saturday Nov 16, 2024 2:11 AM EST |
|
Defendant
Aurobindo Pharma Ltd.
|
|
|
Defendant
Aurobindo Pharma USA, Inc.
|
|
|
Defendant
Hetero Labs Limited
|
|
|
Defendant
Hetero Labs Limited Unit-V
|
|
|
Defendant
Hetero USA, Inc.
|
|
|
Defendant
Hoster Labs Private Limited
|
|
|
Defendant
Sandoz GmbH
|
|
|
Defendant
Sandoz Inc.
|
|
|
Defendant
Sandoz Private Limited
|
|
|
Defendant
Sun Pharmaceutical Industries, Ltd.
|
|
|
Plaintiff
AbbVie Inc.
|
Represented By
|
| Docket last updated: 11/16/2024 2:40 AM EST |
| Thursday, November 14, 2024 | ||
| 6 | 6
service
Summons Issued
Fri 11/15 8:37 AM
Summons Issued as to Aurobindo Pharma Ltd. on 11/14/2024; Aurobindo Pharma USA, Inc. on 11/14/2024; Hetero Labs Limited on 11/14/2024; Hetero Labs Limited Unit-V on 11/14/2024; Hetero USA, Inc. on 11/14/2024; Hoster Labs Private Limited on 11/14/2024; Sandoz GmbH on 11/14/2024; Sandoz Inc. on 11/14/2024; Sandoz Private Limited on 11/14/2024; Sun Pharmaceutical Industries, Ltd. on 11/14/2024.(scs) |
|
|
Att: 1
Summons Issued to Aurobindo Pharma USA, Inc.,
|
||
|
Att: 2
Summons Issued to Hetero Labs Limited Unit-V,
|
||
|
Att: 3
Summons Issued to Hetero Labs Limited,
|
||
|
Att: 4
Summons Issued to Hetero USA, Inc.,
|
||
|
Att: 5
Summons Issued to Hoster Labs Private Limited,
|
||
|
Att: 6
Summons Issued to Sandoz GmbH,
|
||
|
Att: 7
Summons Issued to Sandoz Inc.,
|
||
|
Att: 8
Summons Issued to Sandoz Private Limited,
|
||
|
Att: 9
Summons Issued to Sun Pharmaceutical Industries, Ltd.
|
||
| 5 | 5
misc
Disclosure Statement - Rule 7.1
Fri 11/15 8:29 AM
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (scs) |
|
| 4 | 4
misc
Patent/Trademark Report to Commissioner of Patents
Fri 11/15 8:28 AM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,077,545 B2; 12,103,933 B2; 12,110,297 B2; 12,116,373 B2 ; 12,110,298 B2. (scs) |
|
| 3 | 3
misc
ANDA Form
Fri 11/15 8:26 AM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/24/2024. Date of Expiration of Patent: 10/17/2036. Thirty Month Stay Deadline: 2/16/2027. (scs) |
|
| 2 | 2
misc
Magistrate Consent Forms
Fri 11/15 8:24 AM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
|
| 1 | 1
53
pgs
cmp
Complaint
Fri 11/15 8:24 AM
COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc., Hoster Labs Private Limited, Sandoz GmbH, Sandoz Inc., Sandoz Private Limited, Sun Pharmaceutical Industries, Ltd. ( Filing fee $ 405, receipt number ADEDC-4548912.) - filed by AbbVie Inc..(scs) |
|
|
Att: 1
Exhibit A-E,
|
||
|
Att: 2
Civil Cover Sheet
|
||